Single-cell RNA-seq of murine splenocytes from Bcl6tg/+ and Cd70-/-; Bcl6tg/+ diffuse large B-cell lymphoma mouse models and Cd70-/- and wild-type controls.
We previously defined 5 diffuse large B-cell lymphoma (DLBCL) molecular subtypes (Clusters 1-5), each characterized by specific genetic alterations. In our DLBCL series, CD70 inactivating mutations and copy loss were the most frequent potential genetic bases of immune evasion. CD70 activation of CD27+ T cells promotes CD4+ and CD8+ T-cell expansion and immune surveillance of normal and malignant B cells. CD70 mutations were most common in Cluster 1 DLBCLs, which also exhibited recurrent BCL6 translocations. To assess the consequences of Cd70 deficiency and perturbed CD70/CD27 costimulation on Bcl6-driven lymphomagenesis, we crossed previously generated Cd70-/- and Bcl6tg/+ mice to obtain Cd70-/-; Bcl6tg/+ animals. We observed a significantly increased incidence of DLBCL in Cd70-/-; Bcl6tg/+ compared to Bcl6tg/+ animals, largely involving the spleen. To investigate lymphoma onset and progression and the associated T-cell-mediated anti-tumor immune responses, we performed single-cell RNA sequencing on 91 spleen samples from wild-type, Cd70-/-, Bcl6tg/+, and Cd70-/-; Bcl6tg/+ cohorts. The study included asymptomatic mice at 6, 14, and 18 months, as well as animals euthanized upon developing symptomatic lymphoma.
- Type: Other
- Archive: European Genome-phenome Archive (EGA)
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
| Dataset ID | Description | Technology | Samples |
|---|---|---|---|
| EGAD00001012104 | Illumina NovaSeq 6000 | 91 |
